Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy Volunteers
Clinical trial NCT02781753 · COMPLETED
Trial details
- NCT number
- NCT02781753
- Sponsor
- Tianjin SinoBiotech Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-07
- Primary completion
- 2016-08-02
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.